Clinical Trials on Varicella Zoster Virus Infection in Argentina

Total 324 results

Tiva Group

Unknown

Use of the Nasal Cannula During COVID-19

COVID 19

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.

Acquired Immunodeficiency Syndrome

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires

Not yet recruiting

Congenital Cytomegalovirus: Prevalence in Buenos Aires City (cCMV Prevalence) (cCMV)

Congenital Cytomegalovirus

Argentina
Kirby Institute
Chelsea and Westminster NHS Foundation Trust

Completed

The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)

HIV Infection

Argentina, South Africa, Thailand, United Kingdom
Austral University, Argentina

Unknown

Liver Injury in Patients With COVID-19

Liver Injury

Argentina
Ministry of Public Health, Argentina
Centers for Disease Control and Prevention; Pan American Health Organization

Enrolling by invitation

Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina

Yellow Fever

Argentina
Ariel Dogliotti
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno

Unknown

Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease (CARR-COV-02)

Covid19

Argentina
Hospital Italiano de Buenos Aires

Completed

Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine

Healthcare Workers | Vaccine | Coronavirus 2019

Argentina
Hospital Nacional Profesor Alejandro Posadas

Recruiting

Prevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation. (HINDIP)

Inflammation | Hyponatremia | Dengue

Argentina
Hospital Italiano de Buenos Aires
University of Buenos Aires; Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients

Renal Dialysis | Coronavirus Disease 2019 Vaccines

Argentina
Alba Maria Ropero
Centers for Disease Control and Prevention; Ministry of Public Health, Argentina

Completed

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

Vaccine Response Impaired

Argentina
ViiV Healthcare
GlaxoSmithKline

Completed

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

HIV Infections | Infection, Human Immunodeficiency Virus

Mexico, Peru, Thailand, South Africa, Russian Federation, Argentina, Brazil
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

Argentina
Sanatorio Anchorena San Martin

Completed

Characteristics of Weaning From Mechanical Ventilation in COVID-19 (CovWean)

COVID-19 | Respiration, Artificial

Argentina
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Completed

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? (VALIDATE)

HIV Infections | HIV Infection | Herpes Simplex Type II

Canada, United Kingdom, Argentina, Brazil
Arturo Jauretche National University
University of Buenos Aires; Hospital El Cruce; Universidad Nacional de La Plata; National University of Cuyo

Recruiting

Clinical and Biological Characterization of Post COVID-19 Syndrome

Long COVID

Argentina
Janssen Sciences Ireland UC

Terminated

Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV) (FREESIA)

Respiratory Syncytial Virus Infections

United States, Belgium, Taiwan, Israel, Japan, Argentina, Malaysia, Korea, Republic of, Netherlands, Spain, Australia, Italy, Brazil, France, United Kingdom, Sweden, Bulgaria
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes

COVID-19 Vaccines

Argentina
Hospital Italiano de Buenos Aires

Completed

Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease (COVID-19)

Argentina
Fundacion GESICA
Merck Sharp & Dohme LLC

Recruiting

A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires

Flavivirus Infections | Dengue

Argentina
Laboratorio Pablo Cassará S.R.L.
National Council of Scientific and Technical Research, Argentina; Universidad...

Completed

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

COVID-19 Vaccine

Argentina
Enanta Pharmaceuticals, Inc

Terminated

Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Who Are Infected With Acute Respiratory Syncytial Virus (RSV) of the Upper Respiratory Tract (RSVTx)

Respiratory Syncytial Virus Infections

Spain, Korea, Republic of, Israel, Canada, United States, Italy, France, Belgium, Brazil, Taiwan, Greece, Argentina, Mexico, South Africa, China, Poland, Colombia, Turkey, United Kingdom
Hospital Italiano de Buenos Aires

Recruiting

Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients (IRCIP)

Covid19

Argentina
Sanofi

Completed

Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis

Argentina
Clinica Colon

Completed

Lung Injury (Pulmonary Edema) in COVID-19: Treatment With Furosemide and Negative Fluid Balance (NEGBAL)

COVID-19

Argentina
Nemechek Technologies

Completed

Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients

Severe Acute Respiratory Syndrome Coronavirus 2

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19

Tocilizumab | Severe COVID 19 Pneumonia

Argentina
Novartis Pharmaceuticals

Completed

A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)

Hepatitis B, Chronic

Argentina, Brazil, Germany, Thailand
Hospital Italiano de Buenos Aires
Hospital de Niños R. Gutierrez de Buenos Aires; Ministerio de Salud GCBA

Completed

Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina

Coronavirus Disease 2019

Argentina
Fundación Huésped
ViiV Healthcare

Completed

Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women (TRANSViiV)

HIV Infections

Argentina
ViiV Healthcare
GlaxoSmithKline

Completed

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

HIV Infections | Infection, Human Immunodeficiency Virus

United States, Portugal, Russian Federation, Mexico, Argentina, South Africa, Puerto Rico
Ministry of Public Health, Argentina
Russian Direct Investment Fund

Recruiting

Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina (ECEHeVac)

Covid19 | COVID-19 VACCINE

Argentina
Hospital Italiano de Buenos Aires

Completed

Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia (PLASM-AR)

COVID-19 | SARS-CoV-2 | SARS Virus

Argentina
Janssen Sciences Ireland UC

Terminated

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection

Virus Diseases | Respiratory Syncytial Virus Infections

Australia, Spain, Belgium, Sweden, Netherlands, Brazil, Germany, Argentina, Philippines, United States
Bristol-Myers Squibb

Completed

Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection

Hepatitis B, Chronic

Argentina, France, Italy, Korea, Republic of, Taiwan, United States, Spain, Australia, Brazil
Hospital Privado de Comunidad de Mar del Plata
Austral University, Argentina; Hospital Aleman

Recruiting

Characteristics and Outcomes of Patients With COVID-19 Treated With High-flow Nasal Oxygen and Awake-prone Position (AW-PP_Covid)

COVID-19 | Mortality | Endotracheal Intubation | Respiratory Failure | Prone Position

Argentina
Hospital Italiano de Buenos Aires
Sociedad Argentina de Infectología (SADI) (Argentine Society of Infectious...

Unknown

TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)

COVID-19 | Healthcare Workers | SARS-CoV 2

Argentina
Australian National University
Helwan University; Dr Cipto Mangunkusumo General Hospital; Coney Island Hospital... and other collaborators

Active, not recruiting

Inhaled Heparin for Hospitalised COVID-19 Patients (INHALE-HEP)

Covid19

Indonesia, Argentina, Egypt
RUTI Immunotherapeutics S.L.

Completed

Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

Covid-19

Argentina
Clinica San Camilo, Argentina

Unknown

Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 (NEBUHEPA)

Pneumonia | Covid19

Argentina
Sociedad Argentina de Reumatologia

Completed

Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection (SAR-COVID)

Rheumatic Diseases

Argentina
Sanofi
Regeneron Pharmaceuticals

Completed

Sarilumab COVID-19

Corona Virus Infection

Italy, Japan, Israel, Argentina, Russian Federation, Germany, Spain, Brazil, Chile, Canada, France
Vaxart

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Condyloma

Argentina, Chile, Ecuador, Serbia
Enanta Pharmaceuticals, Inc

Recruiting

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. (RSVHR)

RSV Infection

United States, Poland, Spain, Taiwan, Bulgaria, Argentina, Puerto Rico, Czechia, Brazil, Israel, Malaysia, Netherlands, Slovakia, South Africa
Sara Varea

Completed

Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia

Coronavirus Infection

Spain, Argentina
AiCuris Anti-infective Cures AG
Medpace, Inc.

Recruiting

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (PRIOH-1)

HSV Infection

United States, Italy, Belgium, France, United Kingdom, Germany, Switzerland, Argentina, Australia, Georgia, Greece, Mexico, Israel, Canada
GlaxoSmithKline

Completed

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis

Argentina, Nicaragua
ViiV Healthcare
GlaxoSmithKline

No longer available

An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc

Infection, Human Immunodeficiency Virus

Belgium, Russian Federation, Italy, South Africa, Argentina, Switzerland, Poland
Kirby Institute
ViiV Healthcare; University of Witwatersrand, South Africa; University of Liverpool and other collaborators

Completed

COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings

Coronavirus Infection | HIV-infection/Aids

Uganda, Cameroon, Argentina, Brazil, India, Malaysia, Nigeria, South Africa, Thailand, Zimbabwe
Austral University, Argentina

Unknown

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

Hepatitis C | Cirrhosis | Antiviral Drug Adverse Reaction

Argentina

Clinical Trials on Varicella Zoster Virus Infection in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations